Despite a marked reduction in PDX1-positive cells, a substantial β-cell number remained in STZ-treated MIP-HSD1tg/+ islets, although the comparable hyperglycemia between genotypes from day 2 to 3 indicates these β-cells underwent a period of initial secretory dysfunction (Figure 1). Here, PDX1 is linked to Hyperglycemia.